AMP applauds FDA’s decision to delay final regulatory guidance for laboratory-developed procedures
Bethesda, MD - November 21, 2016 - The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular diagnostic professionals, today applauds the...







